Karyopharm Therapeutics Inc.

Q2 2024 13F Holders

Symbol
KPTI
CUSIP
48576U106
Type
Equity
Class
COM
Num filers
118
Total reported value, excl. options
$60.3 M
Manager Report Date Value ($000) Shares Option Type